Abiomed
American medical device company specializing in heart pumps
Abiomed is an American medical device company that specializes in the development and manufacture of heart pumps. The company is known for its Impella heart pump technology, which is used to support patients with severe heart conditions. Abiomed is headquartered in Danvers, Massachusetts.
History[edit | edit source]
Abiomed was founded in 1981 by Dr. David M. Lederman. The company initially focused on developing artificial hearts and circulatory support devices. Over the years, Abiomed has evolved to become a leader in the field of percutaneous heart pumps.
Products[edit | edit source]
Abiomed's primary product line is the Impella series of heart pumps. These devices are designed to provide temporary support to the heart, allowing it to rest and recover. The Impella pumps are inserted percutaneously and can be used in various clinical settings, including during high-risk percutaneous coronary intervention (PCI) and in cases of cardiogenic shock.
Impella Heart Pumps[edit | edit source]
The Impella heart pumps are small, catheter-based devices that are inserted through the femoral artery and positioned in the left ventricle. They work by drawing blood from the left ventricle and expelling it into the ascending aorta, thereby reducing the workload on the heart and improving cardiac output.
Research and Development[edit | edit source]
Abiomed invests heavily in research and development to advance its heart pump technology. The company collaborates with leading medical institutions and participates in clinical trials to expand the indications for its devices and improve patient outcomes.
Corporate Structure[edit | edit source]
Abiomed is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol ABMD. The company has a global presence, with offices and facilities in several countries.
Impact on Cardiology[edit | edit source]
Abiomed's heart pump technology has had a significant impact on the field of cardiology. The Impella devices have been shown to improve survival rates in patients with severe heart conditions and have become an essential tool in the management of acute heart failure.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
